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representative of the study population in term of the prevalence of systemic co-morbidity, although they did not provide any supporting evidence.
Study design
This was a prospective, randomised clinical trial (RCT), which appears to have been performed in a single centre. The patients were randomly allocated to the alternative anaesthesia procedures according to a computer-generated randomisation schedule. The patients were followed up from the moment they arrived in the operating room until 24 hours after anaesthesia. No loss to follow-up was reported. The authors reported that this was a single-blind study since the anaesthetist in charge of assessing some of the outcomes was not blinded to the anaesthetic technique.
Analysis of effectiveness
The basis of the clinical analysis was intention to treat. The primary health outcomes assessed in the effectiveness analysis for both anaesthetic procedures were: the mean time from the beginning of the anaesthetist's presence until anaesthesia induction was complete; the mean time from the start to the end of surgery; the mean time from the end of surgery until tracheal extubation, arrival in the PACU, and achievement of an Aldrete score of greater than 8; the mean recovery time (i.e. from end of surgery until PACU discharge readiness); the percentage of patients requiring related drug therapy; the incidence of postoperative shivering; the occurrence of adverse events; the percentage of patients who experienced a more pleasant recovery from anaesthesia than expected; and the percentage of completely satisfied patients (i.e. those who would choose the same anaesthesia regimen again).
A questionnaire was used on the first postoperative day to ask patients about postoperative complaints (nausea, vomiting, headache, wound pain, muscle pain, pain at the venous cannula location, sore throat, hoarseness, coughing, thirst and shivering) and satisfaction. The groups were shown to be similar in terms of their age, gender, ASA physical status, height and weight.
Effectiveness results
The mean time from the beginning of the anaesthetist's presence until anaesthesia induction was complete was 66.9 (standard deviation, SD=15.3) minutes in the TIVA-RP group, and 76.3 (SD=11.7) minutes in the BA-FI group, (p<0.001).
The mean time from the start to the end of surgery was 28.4 (SD=11.4) minutes in the TIVA-RP group, and 27.5 (SD=8.6) minutes in the BA-FI group, (p>0.05).
The mean time from the end of surgery until tracheal extubation was 4.6 (SD=3.2) minutes for the TIVA-RP group, and 11.1 (SD=4.9) minutes for the BA-FI group, (p<0.001).
The mean time from the end of surgery until arrival in the PACU was 7.2 (SD=3.1) minutes for the TIVA-RP group, and 14.9 (SD=4.4) minutes for the BA-FI group, (p<0.001).
The mean time from the end of surgery until an Aldrete score of greater than 8 was achieved was 13.1 (SD=13.7)
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The mean recovery time was 77.3 (SD=31.0) minutes in the TIVA-RP group, and 93.9 (SD=47.6) minutes in the BA-FI group, (p<0.05).
In total, 52% of the TIVA-RP patients and 27% of the BA-FI patients needed cardiovascular medication after the anaesthetic procedure. None of the TIVA-RP patients required anti-emetic therapy, compared with 13% of the BA-FI patients. Sixteen per cent of the TIVA-RP patients and 8% of the BA-FI patients needed analgesics for postoperative pain (this difference was not statistically significant).
The incidence of postoperative shivering was significantly higher in the TIVA-RP group (10%) than in the BA-FI group (0%).
The response rate for the questionnaire used to assess the occurrence of adverse events and the patient's satisfaction was 97%.
The occurrence of adverse events was as follows:
nausea occurred in 10% of the TIVA-RP patients and 34% of the BA-FI patients, (p=0.001);
vomiting occurred in 3% of the TIVA-RP patients and 23% of the BA-FI patients, (p=0.002);
coughing occurred in 45% of the TIVA-RP patients and 20% of the BA-FI patients, (p=0.003); and
shivering occurred in 24% of the TIVA-RP patients and 2% of the BA-FI patients, (p<0.001).
A significantly higher proportion of TIVA-RP patients (56%) experienced a more pleasant recovery than expected in comparison with BA-FI patients (33%), (p=0.022).
The proportion of completely satisfied patients was 93.2% in the TIVA-RP group versus 65.6% in the BA-FI group, (p<0.001).
Clinical conclusions
While the mean times from the start to the end of surgery were not significantly different for TIVA-RP in comparison with BA-FI, TIVA-RP had advantages over BA-FI in terms of the recovery times. However, a higher percentage of patients receiving TIVA-RP needed cardiovascular medication and analgesics, and experienced coughing and shivering. On the other hand, a higher percentage of patients in the BA-FI group required anti-emetic therapy and experienced nausea and vomiting. The percentage of patients completely satisfied was significantly higher in the TIVA-RP group.
Modelling
The authors developed a model to simulate the patient flow through an operating suite in order to compare the costeffectiveness of the two anaesthesia regimens under analysis. The type of model used was not reported. Two alternative scenarios were considered according to the operating suite work schedules. One had a given number of cases per day with an unlimited closing time, while in the other the closing time of the operating room was fixed. For the base-case analysis it was assumed that there were three operating theatres and one postanaesthetic recovery room (PACU).
Measure of benefits used in the economic analysis
The summary measure of benefit used in the economic analysis was the number of patients completely satisfied with the anaesthesia regimen. This was obtained from the questionnaire used in the effectiveness analysis. Therefore, the valuation was obtained directly from those patients included in the effectiveness analysis who answered the questionnaire.
